Panel Recommends More Testing for Diabetes Drugs

Law360, New York (July 3, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration should require pharmaceutical companies to conduct studies examining the effect of new diabetes drugs on the heart, an advisory committee recommended Wednesday.

A panel of outside scientific experts voted 14-2 to recommend that the FDA require drugmakers to submit results of long-term clinical trials of drugs for Type 2 diabetes, the most common form of the disease, in order to rule out an unacceptable risk of heart attack.

Even drugs that do not show signs of cardiovascular risk in initial...
To view the full article, register now.